Vaccine model of antiphospholipid syndrome induced by tetanus vaccine

Lupus

Volumn 21, Issue 2, 2012, Pages 195-202

  Dimitrijevic L ^a   Zivkovic I ^a   Stojanovic M ^a   Petrusic V ^a   Zivancevic Simonovic S ^b  

^a Department of Research and Development   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

anticardiolipin antibodies; antiphospholipid syndrome; pregnancy

Indexed keywords

ALUMINUM HYDROXIDE; BETA2 GLYCOPROTEIN 1 ANTIBODY; FREUND ADJUVANT; GLYCEROL; MONOCLONAL ANTIBODY; TETANUS TOXOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; B LYMPHOCYTE ACTIVATION; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; FETUS; FETUS RESORPTION; MOLECULAR MIMICRY; MOUSE STRAIN; NONHUMAN; PASSIVE IMMUNIZATION; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SUBFERTILITY; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; B-LYMPHOCYTES; BETA 2-GLYCOPROTEIN I; FEMALE; FETAL RESORPTION; FREUND'S ADJUVANT; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PREGNANCY; T-LYMPHOCYTES; TETANUS TOXOID;

EID: 84855784438     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311429816     Document Type: Article

References (49)

1. Radway-Bright EL, Inanc M, Isenberg DA. Animal models of the antiphospholipid syndrome. Rheumatology. 1999 ; 38: 591-601 (Pubitemid 29507325)
2. Ahmadi K, Wilson C, Tiwana H, et al. Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. Rheumatology. 1998 ; 37: 1330-1333
3. Bogdanos DP, Mieli-Vergani G, Vergani D. Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter?. Clin Infect Dis. 2005 ; 40: 508-510 (Pubitemid 40270218)
4. Chen LK, Chou YC, Tsai ST, et al. Hepatitis C virus infection related Type 1 diabetes mellitus. Diabet Med. 2005 ; 22: 340-343
5. Tiwana H, Wilson C, Alvarez A, et al. Crossreactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun. 1999 ; 67: 2769-2775 (Pubitemid 29244688)
6. Khamaisi M, Shoenfeld Y, Orbach H. Guillain-Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol. 2004 ; 22: 767-770 (Pubitemid 40045542)
7. Mari A. Is there a causative role of tetanus toxoid vaccination in the development of allergy-like symptoms and the increasing prevalence of atopic diseases?. Med Hypotheses. 2004 ; 63: 875-886 (Pubitemid 39370010)
8. Selmi C, Battezzati PM, Gershwin ME, et al. Vaccines in 21st century: the genetic response and the innocent bystander. Autoimmun Rev. 2005 ; 4: 79-81 (Pubitemid 40255614)
9. Toplak N, Avcin T. Vaccination of healthy subjects and autoantibodies: from mice through dogs to humans. Lupus. 2009 ; 18: 1186-1191
10. Shoenfeld Y. Infections, vaccines and autoimmunity. Lupus. 2009 ; 18: 1127-1128
11. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002 ; 109: 797-804 (Pubitemid 34263156)
12. Blank M, Eisenstein M, Ascherson RA, Cervera R, Schoenfeld Y Infection and Autoimmunity. Schoenfeld Y Rose N, ed. Amsterdam: Elsevier ; 2004: 473-490.
13. Meroni PL. Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. J Autoimmun. 2008 ; 30: 99-103
14. Billiau A, Matthys P. Modes of action of Freud's adjuvants in experimental models of autoimmune diseases. J Leuk Biol. 2001 ; 70: 849-860 (Pubitemid 33151123)
15. Stills HF. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J. 2005 ; 46: 280-293
16. Barton GM, Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol. 2002 ; 14: 380-383 (Pubitemid 34327982)
17. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev. 2004 ; 199: 227-250 (Pubitemid 38736775)
18. Netea MG, Kullberg BJ, de Jong D, et al. NOD2 mediates induction of the antiinflammatory signals induced by TLR2-ligands: implications for Crohn's disease. Eur J Immunol. 2004 ; 34: 2052-2059 (Pubitemid 39256086)
19. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev. 2006 ; 5: 403-408 (Pubitemid 44143033)
20. Ghumman B, Bertram EM, Watts TH. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo. J Immunol. 1998 ; 161: 3262-3270
21. Brewer JM. (How) do aluminum adjuvants work?. Immunol Lett. 2006 ; 102: 10-15
22. Lindblad EB Methods in molecular medicine: vaccine adjuvants-preparation methods and research protocols. O'Hagan DT, ed. Totowa NJ: Humana Press ; 2000: 49-63.
23. Krieglstein KG, Henschen AH, Weller U, et al. Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites. Eur J Biochem. 1991 ; 202: 41-51
24. European Bioinformatics Institute-European Molecular Biology Laboratory [Internet], Cambridgeshire, UK, [cited 2008 June 2]. Available from http://www.ebi.ac.uk/t-coffee/.
25. Farrar JJ, Yen LM, Cook T, et al. Neurological aspects of tropical disease: Tetanus. J Neurol Neurosurg Psychiatry. 2000 ; 69: 292-301
26. Shibuya K, Robinson D, Zonin F, et al. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol. 1998 ; 160: 1708-1716 (Pubitemid 28106456)
27. Zhang F, Liang Z, Matsuki N, et al. A murine locus on chromosome 18 controls NKT cell homeostasis and Th cell differentiation. J Immunol. 2003 ; 171: 4613-4620 (Pubitemid 37310577)
28. International Immunogenetics Information System. http://www.imgt.org/ IMGTrepertoire/ LocusGenes/index.php? repertoire=nomenclatures&species= mouse&group=IGHV.
29. Haines BB, Angeles CV, Parmelee AP, McLean PA, Brodeur PH. Germline diversity of the expressed BALB/c VhJ558 gene family. Mol Immunol. 2001 ; 38: 9-18 (Pubitemid 32718638)
30. Yancopoulos DG, Malynn AB, Alt FW. Developmentally regulated and strain-specific expression of murine Vh gene families. J Exp Med. 1988 ; 168: 417-435
31. Seidl KJ, Wilshire JA, Mackenzie JD, Kantor AB, Herzenberg LA, Herzenberg LA. Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc Natl Acad Sci U S A. 1999 ; 96: 2262-2267 (Pubitemid 29117902)
32. Pellegrini A, Guiñazú N, Aoki MP, et al. Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain. Int Immunol. 2007 ; 19: 1395-1402 (Pubitemid 350131345)
33. Won W-J, Kearney JF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol. 2002 ; 168: 5605-5611 (Pubitemid 34556141)
34. Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol. 2008 ; 180: 4763-4773
35. Pellegrini A, Carrera-Silva EA, Arocena A, et al. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity. Med Microbiol Immunol. 2011 ;:
36. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun. 2000 ; 14: 1-10
37. Stojanović M, Zivković I, Inić-Kanada A, et al. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response. Microbiol Immunol. 2009 ; 53: 89-100
38. Zivkovic I, Stojanovic M, Petrusic V, et al. Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice. Am J Reprod Immunol. 2011 ; 65: 492-502
39. Živković I, Petrušić V, Stojanović M, et al. Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant. Innate Immun. :
40. Zivkovic IP, Stojanovic MM, Petrusic VZ, et al. Network connectivity is shown to change in C57BL/6 mice during a continuing immune response subsequent to tetanus toxoid hyperimmunization. Biol Res. 2010 ; 43: 393-402
41. Radulovic M, Ciric B, Jurisic A, et al Immune regulation in health and disease. Lukic M Mostarica-Stojkovic M Cuperlovic K Colic M, ed. London: Academic Press ; 1997: 205-211.
42. Ivanovic V, Popovic L, Kovacina K, et al. Detection of cross-reacting idiotypes in sera of lymphoma patients by inverse monoclonal radioimmunoassay. Acta Haematol. 1990 ; 84: 64-67 (Pubitemid 20304906)
43. Dimitrijevic LA, Radulovic MI, Ciric BP, et al. Human monoclonal IgM DJ binds to ssDNA and human commensal bacteria. Hum Antibodies. 1999 ; 9: 37-45 (Pubitemid 30099260)
44. Dimitrijevic LA, Stojanovic M, Ciric B, et al. Expression of Y7 cross-reactive idiotope on human IgM molecules. Immunol Invest. 2004 ; 33: 1-14 (Pubitemid 38292591)
45. Dimitrijevic L, Radulovic M, Ciric B, et al. Immunochemical characterization of a murine monoclonal anti-idiotypic antibody. J Immunoassay. 1992 ; 13: 181-196
46. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood. 2007 ; 109: 422-430 (Pubitemid 46105935)
47. Galili U Autoantibodies. Peter JB Shoenfeld Y, ed. Amsterdam: Elsevier ; 1996: 24-30.
48. Raschi E, Testoni C, Bosisio D, et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 2003 ; 101: 3495-3500 (Pubitemid 36857933)
49. Inic-Kanada A, Stojanovic M, Zivkovic I, et al. Murine monoclonal antibody 26 raised against tetanus toxoid cross-reacts with beta2-glycoprotein I: its characteristics and role in molecular mimicry. Am J Reprod Immunol. 2009 ; 61: 39-51